NORMA LILIA SALAIZA SUAZO



DATOS GENERALES NOMBRAMIENTOS
Nombre completo   NORMA LILIA SALAIZA SUAZO
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   29 años

Vigente   TECNICO ACADEMICO TITULAR C TC Definitivo
Facultad de Medicina
Desde 01-01-2008 (fecha inicial de registros en el SIIA)
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI I2013 - 2020
* SNI I - 2011
* PRIDE C - 2022

INFORMACIÓN DE PUBLICACIONES
Firmas  
Salaiza N. Salaiza, N Salaiza, Norma Salaiza-Suazo N. Salaiza-Suazo, Norma Suazo, N
ID's SCOPUS  
6506659945 23393487700 55993743000
Áreas de conocimiento  
Immunology Jcs 2008 Microbiology Multidisciplinary sciences Parasitology
Scie jcr Tropical medicine Agricultural and Biological Sciences (miscellaneous) Hematology History and Philosophy of Science
Immunology Immunology and Allergy Immunology and microbiology (miscellaneous) Infectious Diseases Multidisciplinary
Parasitology Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Coautorías con entidades de la UNAM  
  • Centro de Ciencias de la Atmósfera
  • Instituto de Investigaciones Biomédicas
  • Instituto de Fisiología Celular
  • Instituto de Biotecnología
  • Instituto de Neurobiología en Querétaro, Querétaro
  • Facultad de Ciencias
  • Facultad de Medicina
  • Facultad de Estudios Superiores "Iztacala"
  • Coordinación de Estudios de Posgrado
  • Dirección General de Servicios de Cómputo Académico
Revistas en las que ha publicado  (14):
  1. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Estados Unidos America (2008)
  2. CELLULAR IMMUNOLOGY, Estados Unidos America (2020, 2023)
  3. EXPERIMENTAL PARASITOLOGY, Estados Unidos America (2009, 2013)
  4. Immunobiology, Alemania (2017)
  5. Immunology, Estados Unidos America (2011)
  6. JOURNAL OF IMMUNOLOGY, Estados Unidos America (2003)
  7. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, Países Bajos (2003)
  8. PARASITE IMMUNOLOGY, Estados Unidos America (2007, 2008, 2018, 2019)
  9. PARASITOL RES, (1999)
  10. PARASITOLOGY RESEARCH, Estados Unidos America (2008, 2009, 2013)
  11. Pathogens, Suiza (2022)
  12. PLOS NEGLECTED TROPICAL DISEASES, Estados Unidos America (2010, 2012)
  13. PLOS ONE, Estados Unidos America (2014, 2016, 2024)
  14. TROPICAL MEDICINE & INTERNATIONAL HEALTH, Estados Unidos America (1999)


Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Rista Fuente Citas WoS Citas Scopus
1Eosinophils of patients with localized and diffuse cutaneous leishmaniasis: Differential response to Leishmania mexicana, with insights into mechanisms of damage inflicted upon the parasites by eosinophils1ᵉʳ autor: Salaiza-Suazo N., Porcel-Aranibar R., Cañeda-Guzmán I.C., Ruiz-Remigio A., et al.2024PLOS ONEWoS-id: 001164173200016
Scopus-id: 2-s2.0-85185233010
00
2Alpha-galactosylceramide as adjuvant induces protective cell-mediated immunity against Leishmania mexicana infection in vaccinated BALB/c miceCoautor: Salaiza-Suazo N., Diupotex M., Zamora-Chimal J., Cervantes-Sarabia R.B., et al.2023CELLULAR IMMUNOLOGYWoS-id: 000953113500001
Scopus-id: 2-s2.0-85149325260
00
3Mast-Cell Response to Leishmania mexicana and Sand-Fly Salivary Proteins Is Modulated by OrchiectomyCoautor: Salaiza-Suazo, Norma, Sanchez-Garcia, Laura, Perez-Torres, Armando, Muñoz-Cruz S., et al.2022PathogensWoS-id: 000785302300001
Scopus-id: 2-s2.0-85128019292
12
4TNF contributes to T-cell exhaustion in chronic L. mexicana infections of mice through PD-L1 up-regulationCoautor: Salaiza-Suazo, Norma, Gonzalez-Tafoya, Eddie, Diupotex, Mariana, Zamora-Chimal, Jaime, et al.2020CELLULAR IMMUNOLOGYWoS-id: 000588273500001
Scopus-id: 2-s2.0-85092188579
35
5The mKate fluorescent protein expressed by Leishmania mexicana modifies the parasite immunopathogenicity in BALB/c miceCoautor: Salaiza-Suazo N., Diupotex M., Martínez-Salazar M.B., Escalona-Montaño A.R., et al.2019PARASITE IMMUNOLOGYWoS-id: 000456701000003
Scopus-id: 2-s2.0-85059189762
11
6Dihydrotestosterone enhances growth and infectivity of Leishmania MexicanaCoautor: Salaiza-Suazo N., Sánchez-García L., Wilkins-Rodriguez A., Morales-Montor J., et al.2018PARASITE IMMUNOLOGYWoS-id: 000425029700005
Scopus-id: 2-s2.0-85040709150
89
7NKT cell activation by Leishmania mexicana LPG: Description of a novel pathwayCoautor: Salaiza-Suazo, Norma, Zamora-Chimal, Jaime, Fernandez-Figueroa, Edith A., Ruiz-Remigio, Adriana, et al.2017ImmunobiologyWoS-id: 000390735300039
Scopus-id: 2-s2.0-84981744868
1518
8Entamoeba histolytica Trophozoites and Lipopeptidophosphoglycan Trigger Human Neutrophil Extracellular Traps2ᵒ autor: Salaiza, Norma, Avila, Eva E., Pulido, Julieta, Rodriguez, Mayra C., et al.2016PLOS ONEWoS-id: 000379579500057
Scopus-id: 2-s2.0-84978634522
3440
9NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: A comparative study of TLRs and cytokines2ᵒ autor: Salaiza-Suazo N., Caneda-Guzman, IC, Fernández-Figueroa E.A., Carrada-Figueroa G., et al.2014PLOS ONEWoS-id: 000345558500050
Scopus-id: 2-s2.0-84911499772
2124
10Inhibition of dendritic cell apoptosis by Leishmania mexicana amastigotesCoautor: Salaiza N., Gutiérrez-Kobeh L., De Oyarzabal E., Argueta J., et al.2013PARASITOLOGY RESEARCHWoS-id: 000316363100045
Scopus-id: 2-s2.0-84876406300
1516
11Effect of 1,25(OH)2D3 on BALB/c mice infected with Leishmania mexicanaCoautor: Salaiza-Suazo N., Ramos-Martínez E., Villasenor-Cardoso, MI, López-Vancell M.R., et al.2013EXPERIMENTAL PARASITOLOGYWoS-id: 000322942300003
Scopus-id: 2-s2.0-84878920653
1717
12Disease Severity in Patients Infected with Leishmania mexicana Relates to IL-1 betaCoautor: Salaiza-Suazo N., Fernández-Figueroa E.A., Rangel-Escareño C., Espinosa-Mateos V., et al.2012PLOS NEGLECTED TROPICAL DISEASESWoS-id: 000304758900003
Scopus-id: 2-s2.0-84863663416
4955
13Looking for susceptibility factors in patients with cutaneous leishmaniasis from Tabasco, MexicoCoautor: Salaiza, N, Figueroa, EAF, Rangel, C, Espinosa, V, et al.2011ImmunologyWoS-id: 000297507100438
00
14CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists2ᵒ autor: Salaiza-Suazo N., Hernández-Ruiz J., Carrada G., Escoto S., et al.2010PLOS NEGLECTED TROPICAL DISEASESWoS-id: 000284765900013
Scopus-id: 2-s2.0-78649797454
7680
15PCR for identification of species causing American cutaneous leishmaniasisCoautor: Suazo, N, Berzunza-Cruz M., Bricaire G., Pérez-Montfort R., et al.2009PARASITOLOGY RESEARCHWoS-id: 000262701400026
Scopus-id: 2-s2.0-63849123097
2322
16Leishmania mexicana: Inhibition of camptothecin-induced apoptosis of monocyte-derived dendritic cellsCoautor: Salaiza, N, Valdes-Reyes, L, Argueta, J, Moran, J, et al.2009EXPERIMENTAL PARASITOLOGYWoS-id: 000263858900001
Scopus-id: 2-s2.0-59849096757
1922
17A monoclonal antibody that inhibits Trypanosoma cruzi growth in vitro and its reaction with intracellular triosephosphate isomeraseCoautor: Salaiza N., Cortés-Figueroa A.A., Pérez-Torres A., Cabrera N., et al.2008PARASITOLOGY RESEARCHWoS-id: 000253522900010
Scopus-id: 2-s2.0-39749186619
2020
18Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host2ᵒ autor: Salaiza, N, Villasenor-Cardoso, MI, Delgado, J, Gutierrez-Kobeh, L, et al.2008PARASITE IMMUNOLOGYWoS-id: 000257701200006
Scopus-id: 2-s2.0-64549164136
2024
19Localization of Entamoeba histolytica Amebopore in Amebic Liver Abscesses in HamstersCoautor: Salaiza N., González A., Monterrubio D., Nequiz M., et al.2008ANNALS OF THE NEW YORK ACADEMY OF SCIENCESWoS-id: 000262400000094
Scopus-id: 2-s2.0-57849159958
47
20Monocyte cytokine and costimulatory molecule expression in patients infected with Leishmania mexicanaCoautor: Salaiza N., Carrada G., Cañeda C., Delgado J., et al.2007PARASITE IMMUNOLOGYWoS-id: 000243941500002
Scopus-id: 2-s2.0-33846898733
1716
21The CD43 coreceptor molecule recruits the ?-chain as part of its signaling pathwayCoautor: Salaiza-Suazo N., Cruz-Muñoz M.E., Salas-Vidal E., Becker I., et al.2003JOURNAL OF IMMUNOLOGYWoS-id: 000184667400038
Scopus-id: 2-s2.0-18744433557
2021
22Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-22ᵒ autor: Salaiza N., Becker I., Aguirre M., Delgado J., et al.2003MOLECULAR AND BIOCHEMICAL PARASITOLOGYWoS-id: 000185273100001
Scopus-id: 2-s2.0-17144437953
290299
23The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasisCoautor: Salaiza-Suazo N., Becker I., Volkow P., Velasco-Castrejon O., et al.1999PARASITOL RESWoS-id: 000078275200001
Scopus-id: 2-s2.0-0032960092
2931
24Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome1ᵉʳ autor: Salaiza-Suazo N., Volkow P., Pérez Tamayo R., Moll H., et al.1999TROPICAL MEDICINE & INTERNATIONAL HEALTHWoS-id: 000084856100003
Scopus-id: 2-s2.0-0033452407
3440

Descargar PDF